Senescence hypothesis for the pathogenetic mechanism of chronic obstructive pulmonary disease.

We report herein that pulmonary emphysematous lesions appear to be a dynamic phenomenon that involves not only the gradual loss of alveolar structure but also apoptosis, cellular proliferation, and cellular senescence. Cellular proliferation compensates for increased alveolar cell apoptosis in patients with chronic obstructive pulmonary disease (COPD). However, smoking, age, and the increased cell cycle turnover that compensates for apoptosis accelerate alveolar cell senescence, thereby halting cellular proliferation and tipping the balance toward apoptosis, which, in turn, promotes the formation of emphysematous lesions. As a result, alveolar cells disappear and the emphysematous lesions progress. At the same time, cellular senescence is believed to induce inflammation. More specifically, senescent alveolar cells induce inflammation by producing various inflammatory cytokines in tissue. Lymphocytes and Clara cells may also age more rapidly in the lungs of patients with COPD. Lymphocyte senescence may induce an autoimmune reaction and increase susceptibility to infection, and Clara cell senescence may impair airway regeneration as well as sustain airway inflammation. Thus, cellular senescence may be involved in arrested tissue repair, chronic inflammation, and increased susceptibility to infection, which are the typical features of COPD.

[1]  L. Hayflick.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.

[2]  M. Cosio,et al.  Hypothesis: Does COPD have an autoimmune component? , 2003, Thorax.

[3]  P. Bender,et al.  Cell autonomous expression of inflammatory genes in biologically aged fibroblasts associated with elevated NF-kappaB activity , 2008, Immunity & Ageing.

[4]  Shapiro Sd.  The pathogenesis of emphysema: the elastase:antielastase hypothesis 30 years later. , 1995 .

[5]  A. Agustí,et al.  Telomere shortening in smokers with and without COPD , 2006, European Respiratory Journal.

[6]  B. Beghé,et al.  Marked alveolar apoptosis/proliferation imbalance in end-stage emphysema , 2005, Respiratory research.

[7]  K. Aoshiba,et al.  Alveolar wall apoptosis causes lung destruction and emphysematous changes. , 2003, American journal of respiratory cell and molecular biology.

[8]  S. Fey,et al.  Stress-induced premature senescence and replicative senescence are different phenotypes, proteomic evidence. , 2002, Biochemical pharmacology.

[9]  S. Castiglioni,et al.  Iterleukin 1 alpha is a marker of endothelial cellular senescent , 2006, Immunity & Ageing.

[10]  D. Shelton,et al.  Microarray analysis of replicative senescence , 1999, Current Biology.

[11]  T. Tsuji,et al.  Alveolar cell senescence in patients with pulmonary emphysema. , 2006, American journal of respiratory and critical care medicine.

[12]  C. Franceschi,et al.  Inflamm‐aging: An Evolutionary Perspective on Immunosenescence , 2000 .

[13]  M. Nishimura,et al.  COPD in Japan: the Nippon COPD Epidemiology study , 2004, Respirology.

[14]  E. Ingenito,et al.  The pathogenesis of chronic obstructive pulmonary disease: advances in the past 100 years. , 2005, American journal of respiratory cell and molecular biology.

[15]  D A Lynch,et al.  Endothelial cell death and decreased expression of vascular endothelial growth factor and vascular endothelial growth factor receptor 2 in emphysema. , 2001, American journal of respiratory and critical care medicine.

[16]  A. Aviv,et al.  Obesity, cigarette smoking, and telomere length in women , 2005, The Lancet.

[17]  T. Tsuji,et al.  Cigarette smoke induces senescence in alveolar epithelial cells. , 2004, American journal of respiratory cell and molecular biology.

[18]  C. Weyand,et al.  Ageing, autoimmunity and arthritis: T-cell senescence and contraction of T-cell repertoire diversity – catalysts of autoimmunity and chronic inflammation , 2003, Arthritis research & therapy.

[19]  K. Aoshiba,et al.  Increased levels of cell death and proliferation in alveolar wall cells in patients with pulmonary emphysema. , 2004, Chest.

[20]  L. Hayflick,et al.  THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS 1 , 1964 .

[21]  K. Aoshiba,et al.  Chronic lung inflammation in aging mice , 2007, FEBS letters.

[22]  L. Kaszubowska.  Telomere shortening and ageing of the immune system. , 2008, Journal of physiology and pharmacology : an official journal of the Polish Physiological Society.

[23]  B. Housset,et al.  Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease. , 2009, American journal of respiratory and critical care medicine.

[24]  M. Prelog.  Aging of the immune system: a risk factor for autoimmunity? , 2006, Autoimmunity reviews.

[25]  A. Lloyd.  Limits to lifespan , 2002, Nature Cell Biology.

[26]  T. Suzuki,et al.  Induction of senescence-associated genes by 5-bromodeoxyuridine in HeLa cells , 2001, Experimental Gerontology.

[27]  G. Joos,et al.  Role of apoptosis in the pathogenesis of COPD and pulmonary emphysema , 2006, Respiratory research.

[28]  W. Klepetko,et al.  T cell senescence and contraction of T cell repertoire diversity in patients with chronic obstructive pulmonary disease , 2009, Clinical and experimental immunology.

[29]  L L Schulman,et al.  Correlation of lung surface area to apoptosis and proliferation in human emphysema , 2005, European Respiratory Journal.